Sorbe, B <br/><br/>
Tropisetron (Navoban) in the prevention of chemotherapy-induced nausea and vomiting--the Nordic experience.  [electronic resource] 

 -  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer  Nov 1994 
 - 393-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0941-4355 
<br/><br/><label>Standard No.: </label>10.1007/BF00344055  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antiemetics--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Female<br/>Finland<br/>Humans<br/>Indoles--adverse effects<br/>Male<br/>Middle Aged<br/>Nausea--chemically induced<br/>Neoplasms--drug therapy<br/>Scandinavian and Nordic Countries<br/>Sex Factors<br/>Treatment Outcome<br/>Tropisetron<br/>Vomiting--chemically induced